Literature DB >> 34225008

The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer.

Elizabeth M Martin1, Krystal A Orlando1, Kosuke Yokobori1, Paul A Wade2.   

Abstract

Cellular identity and physiologic function in mammary epithelial cells and in many breast cancers flow from the action of a network of master transcriptional regulators including estrogen receptor alpha, GATA3, and FOXA1. The last decade has seen the completion of multiple large sequencing projects focusing on breast cancer. These massive compendia of sequence data have provided a wealth of new information linking mutation in these transcription factors to alterations in tumor biology and transcriptional program. The emerging details on mutation in cancer, and direct experimental exploration of hypotheses based on it, are now providing a wealth of new information on the roles played by estrogen receptor alpha, GATA3, and FOXA1 in regulating gene transcription and how their combined action contributes to a network shaping cell function in both physiologic and disease states. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34225008      PMCID: PMC8648900          DOI: 10.1016/j.sbi.2021.05.015

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  37 in total

1.  Genomic Characterization of Primary Invasive Lobular Breast Cancer.

Authors:  Christine Desmedt; Gabriele Zoppoli; Gunes Gundem; Giancarlo Pruneri; Denis Larsimont; Marco Fornili; Debora Fumagalli; David Brown; Françoise Rothé; Delphine Vincent; Naima Kheddoumi; Ghizlane Rouas; Samira Majjaj; Sylvain Brohée; Peter Van Loo; Patrick Maisonneuve; Roberto Salgado; Thomas Van Brussel; Diether Lambrechts; Ron Bose; Otto Metzger; Christine Galant; François Bertucci; Martine Piccart-Gebhart; Giuseppe Viale; Elia Biganzoli; Peter J Campbell; Christos Sotiriou
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

2.  Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.

Authors:  Natasha Emmanuel; Kristopher A Lofgren; Esther A Peterson; David R Meier; Eric H Jung; Paraic A Kenny
Journal:  Anticancer Res       Date:  2018-08       Impact factor: 2.480

3.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.

Authors:  Jérôme Eeckhoute; Erika Krasnickas Keeton; Mathieu Lupien; Susan A Krum; Jason S Carroll; Myles Brown
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

4.  Mutation of GATA3 in human breast tumors.

Authors:  Jerry Usary; Victor Llaca; Gamze Karaca; Shafaq Presswala; Mehmet Karaca; Xiaping He; Anita Langerød; Rolf Kåresen; Daniel S Oh; Lynn G Dressler; Per E Lønning; Robert L Strausberg; Stephen Chanock; Anne-Lise Børresen-Dale; Charles M Perou
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

5.  FOXA1 is a key determinant of estrogen receptor function and endocrine response.

Authors:  Antoni Hurtado; Kelly A Holmes; Caryn S Ross-Innes; Dominic Schmidt; Jason S Carroll
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

6.  The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.

Authors:  Bernard Pereira; Suet-Feung Chin; Oscar M Rueda; Hans-Kristian Moen Vollan; Elena Provenzano; Helen A Bardwell; Michelle Pugh; Linda Jones; Roslin Russell; Stephen-John Sammut; Dana W Y Tsui; Bin Liu; Sarah-Jane Dawson; Jean Abraham; Helen Northen; John F Peden; Abhik Mukherjee; Gulisa Turashvili; Andrew R Green; Steve McKinney; Arusha Oloumi; Sohrab Shah; Nitzan Rosenfeld; Leigh Murphy; David R Bentley; Ian O Ellis; Arnie Purushotham; Sarah E Pinder; Anne-Lise Børresen-Dale; Helena M Earl; Paul D Pharoah; Mark T Ross; Samuel Aparicio; Carlos Caldas
Journal:  Nat Commun       Date:  2016-05-10       Impact factor: 14.919

7.  GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network.

Authors:  Motoki Takaku; Sara A Grimm; John D Roberts; Kaliopi Chrysovergis; Brian D Bennett; Page Myers; Lalith Perera; Charles J Tucker; Charles M Perou; Paul A Wade
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

8.  Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling.

Authors:  Silvia-E Glont; Igor Chernukhin; Jason S Carroll
Journal:  Cell Rep       Date:  2019-03-05       Impact factor: 9.423

9.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Authors:  Vasiliki Theodorou; Rory Stark; Suraj Menon; Jason S Carroll
Journal:  Genome Res       Date:  2012-11-21       Impact factor: 9.043

10.  ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.

Authors:  Weiyi Toy; Yang Shen; Helen Won; Bradley Green; Rita A Sakr; Marie Will; Zhiqiang Li; Kinisha Gala; Sean Fanning; Tari A King; Clifford Hudis; David Chen; Tetiana Taran; Gabriel Hortobagyi; Geoffrey Greene; Michael Berger; José Baselga; Sarat Chandarlapaty
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

View more
  1 in total

1.  Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes.

Authors:  Weixu Luo; Yuanshan Han; Xin Li; Zhuo Liu; Pan Meng; Yuhong Wang
Journal:  Genet Res (Camb)       Date:  2022-05-31       Impact factor: 1.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.